Rockwell Medical (RMTI) Gross Profit (QoQ) (2010 - 2026)
Rockwell Medical (RMTI) Gross Profit (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Rockwell Medical | 28.46 Mn | 4.57 Mn | 2.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.30% |
| Dec 31, 2025 | 70.69% |
| Sep 30, 2025 | -9.23% |
| Jun 30, 2025 | -17.72% |
| Mar 31, 2025 | -16.22% |
| Dec 31, 2024 | -41.80% |
| Sep 30, 2024 | 37.12% |
| Jun 30, 2024 | 48.50% |
| Mar 31, 2024 | 6.76% |
| Dec 31, 2023 | 30.34% |
| Sep 30, 2023 | 113.17% |
| Jun 30, 2023 | -60.25% |
| Mar 31, 2023 | 11.07% |
| Dec 31, 2022 | 201.16% |
| Sep 30, 2022 | -55.47% |
| Jun 30, 2022 | 322.01% |
| Mar 31, 2022 | 64.77% |
| Dec 31, 2021 | -578.12% |
| Sep 30, 2021 | -25.57% |
| Jun 30, 2021 | -165.34% |